在维多利亚州开发比较光子-质子规划服务:彼得·麦卡勒姆癌症中心的经验
Roshini Gunewardena1, Lisa Hall1, Michelle Li1,2
1Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Journal of medical radiation sciences
|February 2, 2024
概括
澳大利亚正在开发质子束疗法 (PBT) 服务. 公司内部建立了一个比较光子-质子 (CPP) 规划服务来支持这一点,在规划复杂病例方面获得了丰富的经验,特别是在中枢神经系统癌症方面.
科学领域:
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
背景情况:
- 质子束疗法 (PBT) 是一种先进的辐射疗法,目前在澳大利亚尚未推出.
- 对目前的海外治疗计划和未来的澳大利亚PBT接入来说,比较光子-质子 (CPP) 规划是必不可少的.
- 开发内部的CPP专业知识支持专业发展和未来的PBT设施提案.
研究的目的:
- 建立并报告开发内部比较光子-质子 (CPP) 规划服务的经验.
- 建立PBT规划的当地专业知识,以支持患者获取和未来在维多利亚州开发PBT设施.
主要方法:
- 建立了一个专门的CPP规划资源集.
- 进行员工培训,并制定了内部培训计划.
- 定义了PBT规划参数的标准协议,并审查了所有CPP计划.
主要成果:
- 在54个月内成功完成了62个比较PBT计划.
- 大多数病例 (60%) 涉及儿科患者,超过75%需要中枢神经系统辐射.
- 国际PBT专家审查了计划,证实了其临床可行性.
结论:
- 彼得·麦卡勒姆癌症中心已经在CPP规划方面发展出了重要的内部专业知识.
- 这种本地能力将促进患者选择质子治疗,并支持维多利亚州PBT设施的商业案例.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...


